CONTACT US   |  (864) 397-5101

Elastrin Therapeutics named winner of 2021 InnoVision Award for Technology Development

Elastrin Therapeutics of Simpsonville, SC has been named winner of the 2021 InnoVision Award for Technology Development, organizers have announced.

Elastrin Therapeutics is a biotech startup with technologies to restore hardened and damaged arteries and tissue by targeting the elastic fiber that makes them work.

Founded by Mr.Douglas Mulhall, Dr.Naren Vyavahare, Dr.Charles D. Rice, and Dr. Mirko Stange, the SCRA Client Company has demonstrated proof-of-concept for a patented therapeutic compound that may provide needed repair and restorative function to lungs that have been damaged by the COVID-19 virus. According to Vyavahare, “Elastin is present in lung alveoli that are being degraded by enzymes such as neutrophil elastases and MMPs released by inflammatory cells in COVID-19 infection of lungs. Our elastin targeting nanoparticle can also target drugs to the lungs and prevent lung injury.

Click here to view the winner’s video.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.